PRTN3 and rheumatoid arthritis: The onset of RA is preceded by preclinical immunological changes, e.g., the production of anti-citrullinated peptides antibodies (anti-CCP/ACPA) and rheumatoid factor, which reflect the loss of immunological tolerance to self-antigens (116), and this places B-cells at the center of RA pathogenesis.